Gina R. Petroni
Professor, Public Health Sciences
Bio & Overview
Academic Information
- Department
- Public Health Sciences
- Academic Title
- Professor
Primary Education
- BA, Statistics, Hunter College, New York, NY, 1980
- MA, Applied Mathematics, Hunter College, New York, NY, 1982
- PhD, Biostatistics, University of Michigan, Ann Arbor, MI, 1990
Other Affiliations
- Faculty Director, Biostatistics Shared Resource, Unaligned Members
Research Interests
Selected Publications
Shada AL, Dengel LT, Petroni GR, Smolkin ME, Acton S, Slingluff CL, Infrared thermography of cutaneous melanoma metastases., 2012; The Journal of surgical research. () . PMID: 23043862
Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR, A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer., 2012; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. () . PMID: 23052911
Jones DR, Moskaluk CA, Gillenwater HH, Petroni GR, Burks SG, Philips J, Rehm PK, Olazagasti J, Kozower BD, Bao Y, Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer., 2012; Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(11) 1683-90. PMID: 23059775 | PMCID: PMC3473142
Slingluff Jr, Petroni GR, Chianese-Bullock KA, Smolkin ME, Ross MI, Haas NB, von M, Grosh WW, Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine., 2011; J Clin Oncol. 29(21) 2924-32. PMID: | PMCID: PMC3138719
Slingluff Jr, Petroni GR, Chianese-Bullock KA, Smolkin ME, Ross MI, Haas NB, von M, Grosh WW, Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine., 2011; J Clin Oncol. 29(21) 2924-32. PMID: | PMCID: PMC3138719
Dengel LT, More MJ, Judy PG, Petroni GR, Smolkin ME, Rehm PK, Majewski S, Williams MB, Slingluff CL, Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera., 2011; Annals of surgery. 253(4) 774-8. PMID: 21475019
Slingluff CL, Petroni GR, Chianese-Bullock KA, Smolkin ME, Ross MI, Haas NB, von Mehren M, Grosh WW, Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine., 2011; Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(21) 2924-32. PMID: 21690475 | PMCID: PMC3138719
Schroen AT, Petroni GR, Wang H, Thielen MJ, Gray R, Benedetti J, Wang XF, Sargent DJ, Wickerham DL, Cronin W, Djulbegovic B, Slingluff CL, Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups., 2011; Clinical cancer research : an official journal of the American Association for Cancer Research. 18(1) 256-62. PMID: 21976533 | PMCID: PMC3977198
Harris RC, Chianese-Bullock KA, Petroni GR, Schaefer JT, Brill LB, Molhoek KR, Deacon DH, Patterson JW, Slingluff CL, The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides., 2011; Journal of immunotherapy (Hagerstown, Md. : 1997). 35(1) 78-88. PMID: 22130163 | PMCID: PMC3282210
Schroen AT, Petroni GR, Wang H, Thielen MJ, Sargent D, Benedetti JK, Cronin WM, Wickerham DL, Wang XF, Gray R, Cohn WF, Slingluff CL, Djulbegovic B, Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials., 2011; Clinical trials (London, England). 8(5) 591-600. PMID: 21878447 | PMCID: PMC3474201
Cavaliere R, Petroni G, Lopes MB, Schiff D, Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report., 2010; Cancer. 116(4) 863-70. PMID:
Schaefer JT, Patterson JW, Deacon DH, Smolkin ME, Petroni GR, Jackson EM, Slingluff Jr, Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis., 2010; J Transl Med. 0(8) null. PMID: | PMCID: PMC2936306
Schaefer JT, Patterson JW, Deacon DH, Smolkin ME, Petroni GR, Jackson EM, Slingluff Jr, Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis., 2010; J Transl Med. 8(0) 79.0. PMID: | PMCID: PMC2936306
Slingluff CL, Petroni GR, Smolkin ME, Chianese-Bullock KA, Smith K, Murphy C, Galeassi N, Neese PY, Grosh WW, Nail CJ, Ross M, von M, Haas N, Boisvert ME, Kirkwood JM, Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines., 2010; J Immunother. 33(6) 630-8. PMID:
Jones DR, Taylor MD, Petroni GR, Shu J, Burks SG, Daniel TM, Gillenwater HH, Phase I trial of intrapleural docetaxel administered through an implantable catheter in subjects with a malignant pleural effusion., 2010; J Thorac Oncol. 5(1) 75-81. PMID:
Slingluff Jr, Petroni GR, Olson WC, Smolkin ME, Ross MI, Haas NB, Grosh WW, Boisvert ME, Kirkwood JM, Chianese-Bullock KA, Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial., 2009; Clin Cancer Res. 15(22) 7036-44. PMID: | PMCID: PMC2778314
Smith SM, Johnson J, Cheson BD, Canellos G, Petroni G, Oken M, Duggan D, Hurd D, Gockerman JP, Parker B, Prchal J, Peterson BA, Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691., 2009; Leuk Lymphoma. 0(50) 10.0. PMID:
Thomas CY, Read P, Petroni G, Reibel J, Levine PA, Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer., 2009; Anticancer Res. 0(29) 7.0. PMID:
Blackhall L, Petroni G, Shu J, Baum L, Farace E, A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue., 2009; J Palliat Med. 0(12) 5.0. PMID:
Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR, Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer., 2009; Cancer Lett. 276(2) 196-203. PMID:
Slingluff Jr, Yamshchikov GV, Hogan KT, Hibbitts SC, Petroni GR, Bissonette EA, Patterson JW, Neese PY, Grosh WW, Chianese-Bullock KA, Czarkowski A, Rehm PK, Parekh J, Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines., 2008; Ann Surg Oncol. 15(12) 3538-49. PMID:
Slingluff Jr, Petroni GR, Olson W, Czarkowski A, Grosh WW, Smolkin M, Chianese-Bullock KA, Neese PY, Deacon DH, Nail C, Merrill P, Fink R, Patterson JW, Rehm PK, Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens., 2008; J Clin Oncol. 26(30) 4973-80. PMID: | PMCID: PMC2652084
Chianese-Bullock KA, Irvin Jr, Petroni GR, Murphy C, Smolkin M, Olson WC, Coleman E, Boerner SA, Nail CJ, Neese PY, Yuan A, Hogan KT, Slingluff Jr, A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer., 2008; J Immunother. 31(4) 420-30. PMID:
Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J, Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices., 2008; Menopause. 15(1) 67-73. PMID: | PMCID: NIHMS193084
Slingluff Jr, Petroni GR, Chianese-Bullock KA, Smolkin ME, Hibbitts S, Murphy C, Johansen N, Grosh WW, Yamshchikov GV, Neese PY, Patterson JW, Fink R, Rehm PK, Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting., 2007; Clin Cancer Res. 13(21) 6386-95. PMID:
Nicholson BT, LoRusso AP, Smolkin M, Bovbjerg VE, Petroni GR, Harvey JA, Accuracy of assigned BI-RADS breast density category definitions., 2006; Acad Radiol. 13(9) 1143-9. PMID:
Schroen AT, Petroni GR, Wang H, Gray R, Wang XF, Cronin W, Sargent DJ, Benedetti J, Wickerham DL, Djulbegovic B, Slingluff Jr, Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials., ; Clin Trials. 7(4) 312-21. PMID:
Dengel LT, More MJ, Judy PG, Petroni GR, Smolkin ME, Rehm PK, Majewski S, Williams MB, Slingluff Jr, Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera., ; Ann Surg. 253(4) 774-8. PMID:
Dengel LT, More MJ, Judy PG, Petroni GR, Smolkin ME, Rehm PK, Majewski S, Williams MB, Slingluff Jr, Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera., ; Ann Surg. 253(4) 774-8. PMID:
Slingluff Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH, Immunity to melanoma antigens: from self-tolerance to immunotherapy., ; Adv Immunol. 90(0) 243-95. PMID: